Michael Sapienza: A Dramatic Surge in Colorectal Cancer Screening and Early-stage Diagnoses
Michael Sapienza, Chief Executive Officer of the Colorectal Cancer Alliance, shared a post on LinkedIn:
“This week, the American Medical Association published two American Cancer Society studies showing a dramatic surge in colorectal cancer screening and early-stage diagnoses, after the recommended screening age was lowered from 50 to 45. Findings show:
– A 62% rise in screening rates among 45–49-year-olds from 2019 to 2023
– A steep rise in detection of local-stage tumors — the kind most treatable when caught early
– A 50% increase in early-stage diagnoses from 2021 to 2022
See ACS press release for full findings.
This is not just data. It’s hope in action. These findings reinforce what the Colorectal Cancer Alliance has long championed in its mission to end the disease: early detection saves lives. But there is still more to be done.
Screening rates are lower than where they should be, and rates of advanced-stage disease are still rising. The Alliance State of Screening Study revealed that more than half of Americans prioritize chores over life-saving colorectal cancer screening. Read more here.
We must continue to reinforce the U.S. Preventive Services Task Force CRC screening recommendations and break down barriers to access, while investing in research like Project Cure CRC.
Learn more about the studies here.”
More posts featuring Michael Sapienza.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023